摘要
目的研究HBVT1862变异的生物学意义。方法 采用分子生物学方法,构建 HBV前C/C基因EB病毒真核表达 载体,利用体外定点突变技术诱导前C/C基因T1862变异,经PCR-RFLP初筛并经测序终鉴定出阳性克隆后,以脂质体 介导方法将突变前后的重组质粒转染Cos7细胞,以 ELISA检测 HBeAg的表达量。结果 未突变的重组质粒可稳定表 达HBeAg,突变后的重组质粒未能检测到HBeAg表达。结论HBV前C/C基因1862点突变的真核表达载体的构建, 为体外研究该点突变引起HBV的一系列生物学改变奠定基础。
Objective To study the biological significance of HBV gene mutation at nucleotide (nt) 1862. Methods The EB virus eukarotic expression vector for HBV pre-C/C gene was constructed using molecular biological method, HBV pre-C/C gene mutation at nt 1862 was induced by way of site-specific mutation technique, and identified by PCR-RFLP and sequencing analysis. The resulted recombinant plasmid containing the HBV variant was subsequently transfected into Cos7 cell line mediated by lipofectin, to observe the expression of HBeAg. The cells transfected with the recombinant plasmid containing wild HBV Pre-C/C gene fragment served as control. Results HBeAg expression was detected in the cells transfected with wild recombinant plasmid but not in those with HBV variant transfection. Conclusion The success in the construction of eukarotic expression vector for HBV pre-C/C gene mutation at nt 1862 may pave the way for further studying a series of biological changes of HBV resulted from the mutation addressed in this study.
出处
《第一军医大学学报》
CSCD
北大核心
2001年第4期255-257,共3页
Journal of First Military Medical University
基金
国家自然科学基金!(396302080)
军队医药卫生重点项目!(96Z024)